中药调节慢性心力衰竭心肌能量代谢的研究概况
Research Overview of Traditional Chinese Medicine Regulating Myocardial Energy Metabolism in Chronic Heart Failure
DOI: 10.12677/TCM.2022.112048, PDF,   
作者: 景 丹:上海中医药大学,上海;顼志兵:上海中医药大学,上海;上海中医药大学附属第七人民医院,上海;黄静聪:上海中医药大学附属第七人民医院,上海
关键词: 慢性心力衰竭心肌能量代谢心肌能量代谢障碍中药Chronic Heart Failure Myocardial Energy Metabolism Myocardial Energy Metabolism Disturbance Traditional Chinese Medicine
摘要: 慢性心力衰竭(Chronic Heart Failure,CHF,以下简称心衰)是一种复杂的临床症候群,具有发病率、患病率、死亡率高的特点。近年来,心肌能量代谢障碍对心衰的发生、发展的影响作用已经获得越来越多的承认,心肌能量代谢的有效调节在心衰的治疗方面具有巨大的潜力。中药在心肌能量代谢调节中已经显示出自己的独特优势,如整体治疗、多靶点、个体化、毒副作用小。本文就心衰的能量代谢机制和中药对其的调节作用作一综述。
Abstract: Chronic Heart Failure is a complex clinical syndrome characterized by high incidence rate, high morbidity rate and high mortality rate. In recent years, the influence of myocardial energy meta-bolism disorder on the occurrence and development of heart failure has been more and more recognized. The effective regulation of myocardial energy metabolism has great potential in the treatment of heart failure. Traditional Chinese medicine has shown its unique advantages in the regulation of myocardial energy metabolism, such as overall treatment, multi-target, individuali-zation and small toxic and side effects. This paper reviews the energy metabolism mechanism of heart failure and the regulatory effect of traditional Chinese medicine on it.
文章引用:景丹, 顼志兵, 黄静聪. 中药调节慢性心力衰竭心肌能量代谢的研究概况[J]. 中医学, 2022, 11(2): 323-330. https://doi.org/10.12677/TCM.2022.112048

参考文献

[1] Baman, J.R. and Ahmad, F.S. (2020) Heart Failure. JAMA, 324, 1015. [Google Scholar] [CrossRef] [PubMed]
[2] Hao, G., Wang, X., Chen, Z., et al. (2019) Prevalence of Heart Failure and Left Ventricular Dysfunction in China: The China Hypertension Survey, 2012-2015. European Journal of Heart Failure, 21, 1329-1337. [Google Scholar] [CrossRef] [PubMed]
[3] Castro, P., Gabrielli, L., Verdejo, H., et al. (2010) Heart Energy Metabolism and Its Role in the Treatment of Heart Failure. Revista Medica de Chile, 138, 1028-1039.
[4] Di Lorenzo, A., Iannuzzo, G., Parlato, A., et al. (2020) Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement. Journal of Clinical Medicine, 9, 1266. [Google Scholar] [CrossRef] [PubMed]
[5] Li, J., Guan, X.K. and Liu, R.X. (2019) Role of Chinese Herbal Medicines in Regulation of Energy Metabolism in Treating Cardiovascular Diseases. Chinese Journal of Integrative Medicine, 25, 307-315. [Google Scholar] [CrossRef] [PubMed]
[6] Doenst, T., Nguyen, T.D. and Abel, E.D. (2013) Cardiac Metabolism in Heart Failure: Implications beyond ATP Production. Circulation Research, 113, 709-724. [Google Scholar] [CrossRef
[7] Abdurrachim, D., Luiken, J.J., Nicolay, K., et al. (2015) Good and Bad Consequences of Altered Fatty Acid Metabolism in Heart Failure: Evidence from Mouse Models. Cardiovascular Research, 106, 194-205. [Google Scholar] [CrossRef] [PubMed]
[8] Kolwicz, S.C., Purohit, S. and Tian, R. (2013) Cardiac Metabolism and Its Interactions with Contraction, Growth, and Survival of Cardiomyocytes. Circulation Research, 113, 603-616. [Google Scholar] [CrossRef
[9] Schaffer, J.E. (2002) Fatty Acid Transport: The Roads Taken. American Journal of Physiology Endocrinology and Metabolism, 282, E239-246. [Google Scholar] [CrossRef] [PubMed]
[10] 唐海双, 王清松, 焦炳华, 等. GLUT4在胰岛素调控葡萄糖转运中作用[J]. 生命的化学, 2014, 34(2): 285-290.
[11] Doenst, T., Pytel, G., Schrepper, A., et al. (2010) Decreased Rates of Substrate Oxidation ex Vivo Predict the Onset of Heart Failure and Contractile Dysfunction in Rats with Pressure Overload. Cardiovascular Research, 86, 461-470. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, L., Jaswal, J.S., Ussher, J.R., et al. (2013) Cardiac Insu-lin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure after Pressure-Overload Hypertrophy. Circulation Heart Failure, 6, 1039-1048. [Google Scholar] [CrossRef
[13] Aroor, A.R., Mandavia, C.H. and Sowers, J.R. (2012) Insulin Resistance and Heart Failure: Molecular Mechanisms. Heart Failure Clinics, 8, 609-617. [Google Scholar] [CrossRef] [PubMed]
[14] Nan, J., Zhu, W., Rahman, M.S., et al. (2017) Molecular Regulation of Mitochondrial Dynamics in Cardiac Disease. Biochimica et Biophysica Acta Molecular Cell Research, 1864, 1260-1273. [Google Scholar] [CrossRef] [PubMed]
[15] Cao, Y.P. and Zheng, M. (2019) Mitochondrial Dynamics and Inter-Mitochondrial Communication in the Heart. Archives of Biochemistry and Biophysics, 663, 214-219. [Google Scholar] [CrossRef] [PubMed]
[16] Horton, J.L., Martin, O.J., Lai, L., et al. (2016) Mitochondrial Protein Hyperacetylation in the Failing Heart. JCI Insight, 2, e84897. [Google Scholar] [CrossRef] [PubMed]
[17] Zhou, B. and Tian, R. (2018) Mitochondrial Dysfunction in Pathophysiology of Heart Failure. The Journal of Clinical Investigation, 128, 3716-3726. [Google Scholar] [CrossRef
[18] Peoples, J.N., Saraf, A., Ghazal, N., et al. (2019) Mitochondrial Dysfunction and Oxidative Stress in Heart Disease. Experimental & Molecular Medicine, 51, 1-13. [Google Scholar] [CrossRef] [PubMed]
[19] Tsutsui, H., Kinugawa, S. and Matsushima, S. (2011) Oxidative Stress and Heart Failure. American Journal of Physiology Heart and Circulatory Physiology, 301, H2181-2190. [Google Scholar] [CrossRef] [PubMed]
[20] Van Der Pol, A., Van Gilst, W.H., Voors, A.A., et al. (2019) Treating Oxidative Stress in Heart Failure: Past, Present and Future. European Journal of Heart Failure, 21, 425-435. [Google Scholar] [CrossRef] [PubMed]
[21] Ke, H.Y., Yang, H.Y., Francis, A.J., et al. (2020) Changes in Cellular Ca(2+) and Na(+) Regulation during the Progression towards Heart Failure in the Guinea Pig. The Journal of Physiology, 598, 1339-1359. [Google Scholar] [CrossRef
[22] Bers, D.M. (2006) Altered Cardiac Myocyte Ca Regulation in Heart Failure. Physiology (Bethesda, Md), 21, 380-387. [Google Scholar] [CrossRef] [PubMed]
[23] Williams, G.S., Boyman, L. and Lederer, W.J. (2015) Mito-chondrial Calcium and the Regulation of Metabolism in the Heart. Journal of Molecular and Cellular Cardiology, 78, 35-45. [Google Scholar] [CrossRef] [PubMed]
[24] Gupta, A., Akki, A., Wang, Y., et al. (2012) Creatine Kinase-Mediated Improvement of Function in Failing Mouse Hearts Provides Causal Evidence the Failing Heart Is Energy Starved. The Journal of Clinical Investigation, 122, 291-302. [Google Scholar] [CrossRef
[25] Cao, F., Maguire, M.L., Mcandrew, D.J., et al. (2020) Overexpression of Mitochondrial Creatine Kinase Preserves Cardiac Energetics without Ameliorating Murine Chronic Heart Failure. Basic Research in Cardiology, 115, 12. [Google Scholar] [CrossRef] [PubMed]
[26] 周杰, 马占东, 李忠轩, 等. 心衰的中医古籍文献整理研究[J]. 中国医学创新, 2018, 15(31): 54-57.
[27] 陈可冀, 吴宗贵, 朱明军, 等. 慢性心力衰竭中西医结合诊疗专家共识[J]. 心脑血管病防治, 2016, 16(5): 340-347.
[28] 孙广仁. 中医学的阴气、阳气概念辨析[J]. 中华中医药杂志, 2005, 20(11): 6-8.
[29] Deng, X.H., Liu, J.J., Sun, X.J., et al. (2019) Benzoylaconine Induces Mitochondrial Biogenesis in Mice via Activating AMPK Signaling Cascade. Acta Pharmacologica Sinica, 40, 658-665. [Google Scholar] [CrossRef] [PubMed]
[30] 蒲科婷, 王志琪, 李耀伟, 等. 基于心肌细胞能量代谢及钙稳态探讨附子作用机制[J]. 湖南中医药大学学报, 2020, 40(10): 1293-1297.
[31] Mootha, V.K., Handschin, C., Arlow, D., et al. (2004) Erralpha and Gabpa/b Specify PGC-1alpha-Dependent Oxidative Phosphorylation Gene Expression That Is Altered in Diabetic Muscle. Proceedings of the National Academy of Sciences of the United States of America, 101, 6570-6575. [Google Scholar] [CrossRef] [PubMed]
[32] Jäger, S., Handschin, C., St-Pierre, J., et al. (2007) AMP-Activated Protein Kinase (AMPK) Action in Skeletal Muscle via Direct Phosphorylation of PGC-1alpha. Proceedings of the National Academy of Sciences of the United States of America, 104, 12017-12022. [Google Scholar] [CrossRef] [PubMed]
[33] Yan, Y., Zhang, A., Dong, H., et al. (2017) Toxicity and Detoxification Effects of Herbal Caowu via Ultra Performance Liquid Chromatography/Mass Spectrometry Metabolomics Analyzed Using Pattern Recognition Method. Pharmacognosy Magazine, 13, 683-692. [Google Scholar] [CrossRef] [PubMed]
[34] 毛营营, 栗焕焕, 任晓亮, 等. 附子-甘草药对配伍研究进展[J]. 天津中医药大学学报, 2021, 40(1): 119-127.
[35] Jin, Y., Cui, R., Zhao, L., et al. (2019) Mechanisms of Panax Ginseng Action as an Antidepressant. Cell Proliferation, 52, e12696. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, Q.W., Yu, X.F., Xu, H.L., et al. (2019) Ginsenoside Re Improves Isoproterenol-Induced Myocardial Fibrosis and Heart Failure in Rats. Evidence-Based Complementary and Alternative Medicine: eCAM, 2019, Article ID: 3714508. [Google Scholar] [CrossRef] [PubMed]
[37] Zheng, X., Wang, S., Zou, X., et al. (2017) Ginsenoside Rb1 Improves Cardiac Function and Remodeling in Heart Failure. Experimental Animals, 66, 217-228. [Google Scholar] [CrossRef] [PubMed]
[38] Chen, X., Wang, Q., Shao, M., et al. (2019) Ginsenoside Rb3 Regulates Energy Metabolism and Apoptosis in Cardiomyocytes via Activating PPARα Pathway. Biomedicine & Pharmacotherapy, 120, Article ID: 109487. [Google Scholar] [CrossRef] [PubMed]
[39] Dong, Y., Feng, Z.L., Chen, H.B., et al. (2018) Corni Fructus: A Review of Chemical Constituents and Pharmacological Activities. Chinese Medicine, 13, 34. [Google Scholar] [CrossRef] [PubMed]
[40] Pi, W.X., Feng, X.P., Ye, L.H., et al. (2017) Combination of Morroniside and Diosgenin Prevents High Glucose-Induced Cardiomyocytes Apoptosis. Molecules (Basel, Switzer-land), 22, 163. [Google Scholar] [CrossRef] [PubMed]
[41] Chen, W., Xia, Y., Zhao, X., et al. (2012) The Critical Role of Astragalus Polysaccharides for the Improvement of PPARα [Correction of PPRAα]-Mediated Lipotoxicity in Diabetic Cardiomyopathy. PLoS ONE, 7, e45541. [Google Scholar] [CrossRef] [PubMed]
[42] Zang, Y., Wan, J., Zhang, Z., et al. (2020) An Updated Role of Astragaloside IV in Heart Failure. Biomedicine & Pharmacotherapy, 126, Article ID: 110012. [Google Scholar] [CrossRef] [PubMed]
[43] Kwan, K.K.L., Huang, Y., Leung, K.W., et al. (2019) Danggui Buxue Tang, a Chinese Herbal Decoction Containing Astragali Radix and Angelicae Sinensis Radix, Modulates Mitochondrial Bioenergetics in Cultured Cardiomyoblasts. Frontiers in Pharmacology, 10, Article No. 614. [Google Scholar] [CrossRef] [PubMed]
[44] Dong, Z., Zhao, P., Xu, M., et al. (2017) Astragaloside IV Alleviates Heart Failure via Activating PPARα to Switch Glycolysis to Fatty Acid β-Oxidation. Scientific Reports, 7, Article No. 2691. [Google Scholar] [CrossRef] [PubMed]
[45] Zhou, Y.X., Zhang, H. and Peng, C. (2014) Puerarin: A Review of Pharmacological Effects. Phytotherapy Research: PTR, 28, 961-975. [Google Scholar] [CrossRef] [PubMed]
[46] He, L., Wang, T., Chen, B.W., et al. (2019) Puerarin Inhibits Apoptosis and Inflammation in Myocardial Cells via PPARα Expression in Rats with Chronic Heart Failure. Experimental and Therapeutic Medicine, 18, 3347-3356. [Google Scholar] [CrossRef] [PubMed]
[47] Cheng, W., Wu, P., Du, Y., et al. (2015) Puerarin Improves Cardiac Function through Regulation of Energy Metabolism in Streptozotocin-Nicotinamide Induced Diabetic Mice after Myocardial Infarction. Biochemical and Biophysical Research Communications, 463, 1108-1114. [Google Scholar] [CrossRef] [PubMed]
[48] Chen, P., Liu, J., Ruan, H., et al. (2019) Protective Effects of Salidroside on Cardiac Function in Mice with Myocardial Infarction. Scientific Reports, 9, Article No. 18127. [Google Scholar] [CrossRef] [PubMed]
[49] Ping, Z., Zhang, L.F., Cui, Y.J., et al. (2015) The Protective Effects of Salidroside from Exhaustive Exercise-Induced Heart Injury by Enhancing the PGC-1 α-NRF1/NRF2 Pathway and Mitochondrial Respiratory Function in Rats. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 876825. [Google Scholar] [CrossRef] [PubMed]
[50] Liao, W., Liu, J., Wang, S., et al. (2020) Metabolic Profiling Reveals That Salidroside Antagonizes Hypoxic Injury via Modulating Energy and Lipid Metabolism in Cardiomyocytes. Biomedicine & Pharmacotherapy, 122, Article ID: 109700. [Google Scholar] [CrossRef] [PubMed]
[51] Yun, W.J., Yao, Z.H., Fan, C.L., et al. (2018) Systematic Screening and Characterization of Qi-Li-Qiang-Xin Capsule-Related Xenobiotics in Rats by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Tandem Mass Spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 1090, 56-64. [Google Scholar] [CrossRef] [PubMed]
[52] Li, X., Zhang, J., Huang, J., et al. (2013) A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients with Chronic Heart Failure. Journal of the American College of Cardiology, 62, 1065-1072. [Google Scholar] [CrossRef] [PubMed]
[53] Zhang, J., Wei, C., Wang, H., et al. (2013) Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats. Evidence-Based Complementary and Alternative Medicine: eCAM, 2013, Article ID: 378298. [Google Scholar] [CrossRef] [PubMed]
[54] Li, Y., Ruan, X., Xu, X., et al. (2019) Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway through Energy-Dependent Mechanisms. Frontiers in Pharmacology, 10, Article No. 1095. [Google Scholar] [CrossRef] [PubMed]
[55] Li, L., Li, J., Wang, Q., et al. (2020) Shenmai Injection Protects against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis. Frontiers in Pharmacology, 11, Article No. 815. [Google Scholar] [CrossRef] [PubMed]
[56] Wang, Y., Wang, Q., Li, C., et al. (2017) A Review of Chinese Herbal Medicine for the Treatment of Chronic Heart Failure. Current Pharmaceutical Design, 23, 5115-5124. [Google Scholar] [CrossRef] [PubMed]
[57] Wang, H., Zhang, J., Shi, C.F., et al. (2020) Combination and Distribution Characteristics of Syndromes Related to Traditional Chinese Medicine in Patients with Chronic Heart Failure: Protocol for a Clinical Study. Medicine, 99, e21852. [Google Scholar] [CrossRef